PriceSensitive

Psyched Wellness (CSE:PSYC) signs sales and distribution agreement with TruLife Distribution

Market News, Psychedelics
CSE:PSYC
02 March 2023 11:30 (EDT)
Psyched Wellness

Psyched Wellness Amanita Muscaria Extract (AME-1) product Calm

Psyched Wellness (PSYC) has signed a sales and distribution agreement with TruLife Distribution to sell/distribute Psyched’s product, Calm.

TruLife has national coverage and will accelerate Psyched’s proprietary Amanita Muscaria Extract (AME-1) product, Calm and all successive Psyched Wellness brands across multiple sales verticals.

The TruLife team will focus on facilitating listings and scale through 3rd party eComm marketplaces and retail chains.

Matthew Singh, Chief Commercial Officer of Psyched Wellness, commented on the announcement.

“This is another big step for Psyched Wellness and all our affiliates. Calm has proved itself from a product efficacy standpoint; now, our focus shifts to increasing visibility and listings. TruLife has an incredible track record in our targeted sales and distribution verticals. Working with Brian Gould and his team will allow us to accelerate our listing conversations and provide the ability to fulfill immediately at a commercial scale. We are excited to add their team to our already stellar and growing list of partners.”

TruLife Distribution is a multi-disciplinary brand and distribution house. With longstanding industry relations in the United States, they can provide full-stack corporate support. The agreement with Psyched Wellness covers the warehousing, sale, and distribution of Calm (and successive SKUs). It also supports digital scale and annual planning.

Psyched Wellness is a Canadian-based health supplements company. It focuses on the distribution of mushroom-derived products and associated consumer packaged goods.

Psyched Wellness Ltd (PSYC) opened trading at C$0.065 per share.


Related News